Hematologic responses with DMT. (A) Waterfall plot of best hematologic responses. (B) OS stratified by hematologic responses at 3 months. (C) TTNT or death among hematologic responders stratified by depth of response at 3 months. Panels B and C show 3-month landmark analyses; the 0 time point represents initiation of daratumumab.